Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06028984 · ClinicalTrials.gov registry record · NA

Self-guided Treatment for Depression

A NA study of Major Depressive Disorder, sponsored by Big Health.

Active
Registry status
NA
Development phase
248
Enrollment target
1
Study location

NCT06028984 is a NA study of Major Depressive Disorder that is active but no longer recruiting, run by Big Health. The registered enrollment target is 248 participants, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (34% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06028984, a NA study of Major Depressive Disorder, is active but no longer recruiting, sponsored by Big Health.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
248 participants
Enrollment target
1
Study location

Study Summary

This study will examine the efficacy and safety of a self-guided digital therapeutic app for the adjunct treatment of Major Depressive Disorder compared to a control app in adolescents and adults.

Conditions Studied

Interventions

  • DEVICE Intervention app
  • OTHER Control app

Study Locations (1)

California

  • Big Health, Inc. - San Francisco

Trial Details

FieldValue
Enrollment Target 248 participants
Start Date 2023-10-12
Est. Completion 2025-09
Phase NA

Sponsor

Big Health

4 total trials

What the Registry Record Tells You About NCT06028984

The ClinicalTrials.gov registry entry for NCT06028984 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 248 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (34% lower). The listed sponsor is Big Health, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 2 interventions - of which Intervention app is the first listed.

NCT06028984 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06028984 about?

NCT06028984 is a clinical study titled "Self-guided Treatment for Depression". This study will examine the efficacy and safety of a self-guided digital therapeutic app for the adjunct treatment of Major Depressive Disorder compared to a control app in adolescents and adults.

What is the current status of trial NCT06028984?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 248 participants. The study started on 2023-10-12. Estimated completion is 2025-09.

What conditions does trial NCT06028984 study?

This clinical trial studies the following conditions: Major Depressive Disorder.

What interventions are being tested in trial NCT06028984?

The interventions under investigation include: Intervention app (DEVICE), Control app (OTHER).

Who is sponsoring clinical trial NCT06028984?

This trial is sponsored by Big Health, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06028984 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.